Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Status:
Completed
Trial end date:
2000-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Bone marrow transplantation may be able to replace immune cells that were
destroyed by chemotherapy and radiation therapy used to kill tumor cells.
PURPOSE: Phase II trial to study the effectiveness of bone marrow transplantation in treating
patients who have hematologic cancer.